 | • レポートコード：20QY06-01074 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、エリスロポエチン薬のグローバル市場について種類別（エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他）、用途別（貧血、腎障害、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・エリスロポエチン薬市場の概要 ・世界の主要地域別エリスロポエチン薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のエリスロポエチン薬市場規模2015-2026：種類別（エポエチンアルファ、ダルベポエチンアルファ、エポエチンベータ、その他） ・世界のエリスロポエチン薬市場規模2015-2026：用途別（貧血、腎障害、その他） ・エリスロポエチン薬の北米市場規模2015-2020 ・エリスロポエチン薬のヨーロッパ市場規模2015-2020 ・エリスロポエチン薬の中国市場規模2015-2020 ・エリスロポエチン薬の日本市場規模2015-2020 ・エリスロポエチン薬の東南アジア市場規模2015-2020 ・エリスロポエチン薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Amgen、Johnson & Johnson、Roche、Galenica、Emcure、Kyowa Hakko Kirin、3SBio、Biocon、LG Life Sciences） ・エリスロポエチン薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・エリスロポエチン薬の市場動向・機会・課題 ・調査の結論 |
Erythropoietin drugs are also known as hematopoietin. It is a glycoprotein hormone that controls erythropoiesis or production of RBC. They are used in treatment of different diseases like cancer, chronic renal diseases,
Global erythropoietin drug market is segmented on the basis of type of product into biosimilars, first generation formulation and second generation formulation. On the basis of application market is segmented as oncology, renal diseases, HIV and other and on the basis of end user they are segmented into hospital and pharmacy.
Market Analysis and Insights: Global Erythropoietin Drug Market
The global Erythropoietin Drug market was valued at US$ 8482.1 million in 2019 and will reach US$ 12630 million by the end of 2026, growing at a CAGR of 5.8% during 2020-2026.
Global Erythropoietin Drug Scope and Market Size
The global Erythropoietin Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erythropoietin Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Erythropoietin Drug market is segmented into
Epoetin-alfa
Darbepoetin-alfa
Epoetin-beta
Others
Segment by Application, the Erythropoietin Drug market is segmented into
Anemia
Kidney Disorders
Other
The Erythropoietin Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Erythropoietin Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Erythropoietin Drug Market Share Analysis
Erythropoietin Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Erythropoietin Drug business, the date to enter into the Erythropoietin Drug market, Erythropoietin Drug product introduction, recent developments, etc.
The major vendors covered:
Amgen
Johnson & Johnson
Roche
Galenica
Emcure
Kyowa Hakko Kirin
3SBio
Biocon
LG Life Sciences
Table of Contents
1 Erythropoietin Drug Market Overview
1.1 Erythropoietin Drug Product Scope
1.2 Erythropoietin Drug Segment by Type
1.2.1 Global Erythropoietin Drug Sales by Type (2020-2026)
1.2.2 Epoetin-alfa
1.2.3 Darbepoetin-alfa
1.2.4 Epoetin-beta
1.2.5 Others
1.3 Erythropoietin Drug Segment by Application
1.3.1 Global Erythropoietin Drug Sales Comparison by Application (2020-2026)
1.3.2 Anemia
1.3.3 Kidney Disorders
1.3.4 Other
1.4 Erythropoietin Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Erythropoietin Drug Sales Growth Rate (2015-2026)
1.4.2 Global Erythropoietin Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Erythropoietin Drug Price Trends (2015-2026)
2 Erythropoietin Drug Estimate and Forecast by Region
2.1 Global Erythropoietin Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Erythropoietin Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Erythropoietin Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Erythropoietin Drug Revenue Market Share by Region (2015-2020)
2.3 Global Erythropoietin Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Erythropoietin Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Erythropoietin Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Erythropoietin Drug Estimates and Projections (2015-2026)
2.4.2 Europe Erythropoietin Drug Estimates and Projections (2015-2026)
2.4.3 China Erythropoietin Drug Estimates and Projections (2015-2026)
2.4.4 Japan Erythropoietin Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Erythropoietin Drug Estimates and Projections (2015-2026)
2.4.6 India Erythropoietin Drug Estimates and Projections (2015-2026)
3 Global Erythropoietin Drug Competition Landscape by Players
3.1 Global Top Erythropoietin Drug Players by Sales (2015-2020)
3.2 Global Top Erythropoietin Drug Players by Revenue (2015-2020)
3.3 Global Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin Drug as of 2019)
3.4 Global Erythropoietin Drug Average Price by Company (2015-2020)
3.5 Manufacturers Erythropoietin Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Erythropoietin Drug Players (Opinion Leaders)
4 Global Erythropoietin Drug Market Size by Type
4.1 Global Erythropoietin Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Erythropoietin Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Erythropoietin Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Erythropoietin Drug Price by Type (2014-2020)
4.2 Global Erythropoietin Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Erythropoietin Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Erythropoietin Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Erythropoietin Drug Price Forecast by Type (2021-2026)
5 Global Erythropoietin Drug Market Size by Application
5.1 Global Erythropoietin Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Erythropoietin Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Erythropoietin Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Erythropoietin Drug Price by Application (2015-2020)
5.2 Global Erythropoietin Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Erythropoietin Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Erythropoietin Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Erythropoietin Drug Price Forecast by Application (2021-2026)
3 North America Erythropoietin Drug Market Facts & Figures
3.2 North America Erythropoietin Drug Sales Market Share by Company (2015-2020)
3.3 North America Erythropoietin Drug Sales Market Share by Type (2015-2020)
3.4 North America Erythropoietin Drug Sales Market Share by Application (2015-2020)
4 Europe Erythropoietin Drug Market Facts & Figures
4.2 Europe Erythropoietin Drug Sales Market Share by Company (2015-2020)
4.3 Europe Erythropoietin Drug Sales Market Share by Type (2015-2020)
4.4 Europe Erythropoietin Drug Sales Market Share by Application (2015-2020)
5 China Erythropoietin Drug Market Facts & Figures
5.2 China Erythropoietin Drug Sales Market Share by Company (2015-2020)
5.3 China Erythropoietin Drug Sales Market Share by Type (2015-2020)
5.4 China Erythropoietin Drug Sales Market Share by Application (2015-2020)
6 Japan Erythropoietin Drug Market Facts & Figures
6.2 Japan Erythropoietin Drug Sales Market Share by Company (2015-2020)
6.3 Japan Erythropoietin Drug Sales Market Share by Type (2015-2020)
6.4 Japan Erythropoietin Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Erythropoietin Drug Market Facts & Figures
7.2 Southeast Asia Erythropoietin Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Erythropoietin Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Erythropoietin Drug Sales Market Share by Application (2015-2020)
8 India Erythropoietin Drug Market Facts & Figures
8.2 India Erythropoietin Drug Sales Market Share by Company (2015-2020)
8.3 India Erythropoietin Drug Sales Market Share by Type (2015-2020)
8.4 India Erythropoietin Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Erythropoietin Drug Business
12.1 Amgen
12.1.1 Amgen Erythropoietin Drug Corporation Information
12.1.2 Amgen Erythropoietin Drug Business Overview and Total Revenue
12.1.3 Amgen Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen Erythropoietin Drug Products Offered
12.1.5 Amgen Recent Development
12.2 Johnson & Johnson
12.2.1 Johnson & Johnson Erythropoietin Drug Corporation Information
12.2.2 Johnson & Johnson Erythropoietin Drug Business Overview and Total Revenue
12.2.3 Johnson & Johnson Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Johnson & Johnson Erythropoietin Drug Products Offered
12.2.5 Johnson & Johnson Recent Development
12.3 Roche
12.3.1 Roche Erythropoietin Drug Corporation Information
12.3.2 Roche Erythropoietin Drug Business Overview and Total Revenue
12.3.3 Roche Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Erythropoietin Drug Products Offered
12.3.5 Roche Recent Development
12.4 Galenica
12.4.1 Galenica Erythropoietin Drug Corporation Information
12.4.2 Galenica Erythropoietin Drug Business Overview and Total Revenue
12.4.3 Galenica Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Galenica Erythropoietin Drug Products Offered
12.4.5 Galenica Recent Development
12.5 Emcure
12.5.1 Emcure Erythropoietin Drug Corporation Information
12.5.2 Emcure Erythropoietin Drug Business Overview and Total Revenue
12.5.3 Emcure Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Emcure Erythropoietin Drug Products Offered
12.5.5 Emcure Recent Development
12.6 Kyowa Hakko Kirin
12.6.1 Kyowa Hakko Kirin Erythropoietin Drug Corporation Information
12.6.2 Kyowa Hakko Kirin Erythropoietin Drug Business Overview and Total Revenue
12.6.3 Kyowa Hakko Kirin Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Kyowa Hakko Kirin Erythropoietin Drug Products Offered
12.6.5 Kyowa Hakko Kirin Recent Development
12.7 3SBio
12.7.1 3SBio Erythropoietin Drug Corporation Information
12.7.2 3SBio Erythropoietin Drug Business Overview and Total Revenue
12.7.3 3SBio Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 3SBio Erythropoietin Drug Products Offered
12.7.5 3SBio Recent Development
12.8 Biocon
12.8.1 Biocon Erythropoietin Drug Corporation Information
12.8.2 Biocon Erythropoietin Drug Business Overview and Total Revenue
12.8.3 Biocon Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Biocon Erythropoietin Drug Products Offered
12.8.5 Biocon Recent Development
12.9 LG Life Sciences
12.9.1 LG Life Sciences Erythropoietin Drug Corporation Information
12.9.2 LG Life Sciences Erythropoietin Drug Business Overview and Total Revenue
12.9.3 LG Life Sciences Erythropoietin Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 LG Life Sciences Erythropoietin Drug Products Offered
12.9.5 LG Life Sciences Recent Development
13 Erythropoietin Drug Manufacturing Cost Analysis
13.1 Erythropoietin Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Erythropoietin Drug
13.4 Erythropoietin Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Erythropoietin Drug Distributors List
14.3 Erythropoietin Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Erythropoietin Drug Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Erythropoietin Drug Sales (K Units) Comparison by Application (2020-2026)
Table 3. Global Market Erythropoietin Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Erythropoietin Drug Sales (K Units) by Region (2015-2020)
Table 5. Global Erythropoietin Drug Sales Market Share by Region (2015-2020)
Table 6. Global Erythropoietin Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Erythropoietin Drug Revenue Share by Region (2015-2020)
Table 8. Global Erythropoietin Drug Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Erythropoietin Drug Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Erythropoietin Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Erythropoietin Drug Revenue Share Forecast by Region (2021-2026)
Table 12. Global Erythropoietin Drug (K Units) of Key Companies (2015-2020)
Table 13. Global Erythropoietin Drug Sales Share by Company (2015-2020)
Table 14. Global Erythropoietin Drug Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Erythropoietin Drug Revenue Share by Company (2015-2020)
Table 16. Global Erythropoietin Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Erythropoietin Drug as of 2019)
Table 17. Global Erythropoietin Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Erythropoietin Drug Manufacturing Sites and Area Served
Table 19. Manufacturers Erythropoietin Drug Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Erythropoietin Drug Players
Table 22. Global Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 23. Global Erythropoietin Drug Sales Share by Type (2015-2020)
Table 24. Global Erythropoietin Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Erythropoietin Drug Price (K Units) by Type (2015-2020)
Table 26. Global Erythropoietin Drug Sales Share by Type (2021-2026)
Table 27. Global Erythropoietin Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Erythropoietin Drug Revenue Share by Type (2021-2026)
Table 29. Global Erythropoietin Drug Price (K Units) by Type (2021-2026)
Table 30. Global Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 31. Global Erythropoietin Drug Sales Share by Application (2015-2020)
Table 32. Global Erythropoietin Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Erythropoietin Drug Price (K Units) by Application (2015-2020)
Table 34. Global Erythropoietin Drug Sales (K Units) by Application (2021-2026)
Table 35. Global Erythropoietin Drug Sales Share by Application (2021-2026)
Table 36. Global Erythropoietin Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Erythropoietin Drug Revenue Share by Application (2021-2026)
Table 38. Global Erythropoietin Drug Price (K Units) by Application (2021-2026)
Table 39. United States Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 40. United States Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 41. United States Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 42. United States Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 43. United States Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 44. United States Erythropoietin Drug Sales Market Share by Application (2015-2020)
Table 45. Europe Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 46. Europe Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 47. Europe Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 48. Europe Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 49. Europe Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 50. Europe Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 51. China Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 52. China Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 53. China Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 54. China Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 55. China Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 56. China Erythropoietin Drug Sales Market Share by Application (2015-2020)
Table 57. Japan Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 58. Japan Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 59. Japan Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 60. Japan Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 61. Japan Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 62. Japan Erythropoietin Drug Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Erythropoietin Drug Sales Market Share by Application (2015-2020)
Table 69. India Erythropoietin Drug Sales (K Units) by Company (2015-2020)
Table 70. India Erythropoietin Drug Sales Market Share by Company (2015-2020)
Table 71. India Erythropoietin Drug Sales (K Units) by Type (2015-2020)
Table 72. India Erythropoietin Drug Sales Market Share by Type (2015-2020)
Table 73. India Erythropoietin Drug Sales (K Units) by Application (2015-2020)
Table 74. India Erythropoietin Drug Sales Market Share by Application (2015-2020)
Table 75. Amgen Corporation Information
Table 76. Amgen Description and Business Overview
Table 77. Amgen Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Amgen Erythropoietin Drug Product
Table 79. Amgen Recent Development
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Johnson & Johnson Erythropoietin Drug Product
Table 84. Johnson & Johnson Recent Development
Table 85. Roche Corporation Information
Table 86. Roche Description and Business Overview
Table 87. Roche Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Roche Erythropoietin Drug Product
Table 89. Roche Recent Development
Table 90. Galenica Corporation Information
Table 91. Galenica Description and Business Overview
Table 92. Galenica Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Galenica Erythropoietin Drug Product
Table 94. Galenica Recent Development
Table 95. Emcure Corporation Information
Table 96. Emcure Description and Business Overview
Table 97. Emcure Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Emcure Erythropoietin Drug Product
Table 99. Emcure Recent Development
Table 100. Kyowa Hakko Kirin Corporation Information
Table 101. Kyowa Hakko Kirin Description and Business Overview
Table 102. Kyowa Hakko Kirin Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Kyowa Hakko Kirin Erythropoietin Drug Product
Table 104. Kyowa Hakko Kirin Recent Development
Table 105. 3SBio Corporation Information
Table 106. 3SBio Description and Business Overview
Table 107. 3SBio Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. 3SBio Erythropoietin Drug Product
Table 109. 3SBio Recent Development
Table 110. Biocon Corporation Information
Table 111. Biocon Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Biocon Description and Business Overview
Table 113. Biocon Erythropoietin Drug Product
Table 114. Biocon Recent Development
Table 115. LG Life Sciences Corporation Information
Table 116. LG Life Sciences Erythropoietin Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. LG Life Sciences Description and Business Overview
Table 118. LG Life Sciences Erythropoietin Drug Product
Table 119. LG Life Sciences Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Erythropoietin Drug Distributors List
Table 123. Erythropoietin Drug Customers List
Table 124. Market Key Trends
Table 125. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 126. Key Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Erythropoietin Drug Product Picture
Figure 2. Global Erythropoietin Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Erythropoietin Drug Market Share by Application in 2020 & 2026
Figure 6. Anemia Examples
Figure 7. Kidney Disorders Examples
Figure 8. Other Examples
Figure 9. Global Erythropoietin Drug Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Erythropoietin Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Erythropoietin Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Erythropoietin Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Erythropoietin Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Erythropoietin Drug Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Erythropoietin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Erythropoietin Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Erythropoietin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Erythropoietin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Erythropoietin Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Erythropoietin Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Erythropoietin Drug Players Market Share by Revenue in Erythropoietin Drug 2015 & 2019
Figure 27. Erythropoietin Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Erythropoietin Drug Revenue Share by Type (2015-2020)
Figure 29. Global Erythropoietin Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Erythropoietin Drug Revenue Share by Application (2015-2020)
Figure 31. Global Erythropoietin Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Erythropoietin Drug Sales Market Share by Type in 2019
Figure 33. United States Erythropoietin Drug Sales Market Share by Type in 2019
Figure 34. Europe Erythropoietin Drug Sales Market Share by Company in 2019
Figure 35. Europe Erythropoietin Drug Sales Market Share by Type in 2019
Figure 36. Europe Erythropoietin Drug Sales Market Share by Application in 2019
Figure 37. China Erythropoietin Drug Sales Market Share by Company in 2019
Figure 38. China Erythropoietin Drug Sales Market Share by Type in 2019
Figure 39. China Erythropoietin Drug Sales Market Share by Application in 2019
Figure 40. Japan Erythropoietin Drug Sales Market Share by Company in 2019
Figure 41. Japan Erythropoietin Drug Sales Market Share by Type in 2019
Figure 42. Japan Erythropoietin Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Erythropoietin Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Erythropoietin Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Erythropoietin Drug Sales Market Share by Application in 2019
Figure 46. India Erythropoietin Drug Sales Market Share by Company in 2019
Figure 47. India Erythropoietin Drug Sales Market Share by Type in 2019
Figure 48. India Erythropoietin Drug Sales Market Share by Application in 2019
Figure 49. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Galenica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Emcure Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. 3SBio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. LG Life Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Key Raw Materials Price Trend
Figure 59. Manufacturing Cost Structure of Erythropoietin Drug
Figure 60. Manufacturing Process Analysis of Erythropoietin Drug
Figure 61. Erythropoietin Drug Industrial Chain Analysis
Figure 62. Channels of Distribution
Figure 63. Distributors Profiles
Figure 64. Porter's Five Forces Analysis
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
エリスロポエチンの世界市場レポート2020 A recently published report by QY Research titled Global Erythropoietin Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate dat…- エリスロポエチン（EPO）薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Erythropoietin (EPO) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.5% in the forecast period of 2020 to 2025 and will expected to reach USD 10830 million by 2025, from USD 8727.6 million in 2019. The Erythropoi…
- EPOバイオマーカーの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global EPO Biomarkers market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The EPO Biomarkers market report p…
- 象皮病薬の世界市場レポート2020 Market Analysis and Insights: Global Elephantiasis Drug Market The global Elephantiasis Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Elephantiasis Drug Scope and Market Size The global Elephantias…
- 植物薬の世界市場レポート2020 Market Analysis and Insights: Global Botanical Drug Market The global Botanical Drug market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Botanical Drug Scope and Market Size The global Botanical Drug market i…